Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 20/20 | 0.61 |
| ▸ | NR3C2 | P08235 | 16/20 | 0.61 |
| ▸ | PGR | P06401 | 14/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27757425 | 0.93 | NR3C1 (0.53) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL9988027 | 0.88 | NR3C1 (0.74) | NR3C1NR3C2PGR | |
| SCHEMBL1635118 | 0.88 | NR3C1 (0.79) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL293443 | 0.87 | NR3C1 (0.81) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL292412 | 0.85 | NR3C1 (0.81) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL291098 | 0.85 | NR3C1 (0.65) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL447415 | 0.85 | NR3C1 (0.66) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL290370 | 0.80 | NR3C1 (0.82) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL1633429 | 0.79 | NR3C1 (0.81) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL290758 | 0.78 | NR3C1 (0.82) | NR3C1NR3C2PGRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101522187-A | Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases | BAUSCH & LOMB (US) | 2009-09-02 | — | — | CN | disclosed |
| CN-101522196-A | Treatment of infections and their sequelae with combined isolated glucocorticoid receptor agonists and anti-infective agents | BAUSCH & LOMB (US) | 2009-09-02 | — | — | CN | disclosed |